#psychedelics

Researchers at UC San Francisco and Imperial College London report that one high dose of psilocybin was linked to lasting changes in brain organization, with short-term shifts in neural entropy predicting later gains in-

Even without full detail in the supplied excerpt, the signal is clear: psychedelic treatments have moved closer to the center of US health policy discussion.

A new federal push to speed access to psychedelic treatments and revisit their status as controlled substances signals a significant policy shift in how Washington approaches mental health therapies.

A new study found scant evidence for endogenous DMT in rat brains and no sign that serotonin terminals formed or retained the compound, reopening a contentious scientific argument rather than settling it.

A new Nature Medicine mega-analysis pooled 11 neuroimaging datasets across five psychedelics and found a common pattern of altered connectivity linking higher-order and sensory brain systems.

Otsuka is acquiring private biotech Transcend Therapeutics in a deal worth roughly $1.2 billion, extending big pharma’s interest in neuropsychiatric medicines modeled on the therapeutic promise associated with psychedel

A new study in mice suggests psychedelic compounds make the brain prioritize stored memories over real sensory input — causing perception to be driven by internal models rather than present reality.

Researchers from the University of Southern Denmark and Bern University Hospital found no evidence that the rat brain produces or stores DMT in serotonin-releasing neurons, undermining a decades-old hypothesis about the psychedelic compound's natural role in brain chemistry.